DLA Piper has advised Altesa BioSciences, Inc. Altesa BioSciences, Inc., a clinical-stage pharmaceutical company, has secured US$75 million through a Series B financing round. The investment…
Altesa BioSciences Raises US$75 Million in Series B Financing
